Radboud Translational Medicine B.V.
- Address
- Geert Grooteplein Noord 21, Route 142, 6525 EZ Nijmegen, The Netherlands
Radboud Translational Medicine B.V.
Radboud Translational Medicine B.V. is a specialized clinical research organization dedicated to advancing innovative treatment strategies in oncology. The center focuses on translating scientific discoveries into clinical practice, with particular expertise in evaluating organ-preserving approaches for cancer treatment.
- Early-stage rectal cancer management and rectal-preserving therapies
- Comparative effectiveness research in surgical versus non-surgical oncological interventions
- Patient-centered treatment approaches incorporating patient preferences in therapeutic decision-making
The center demonstrates specialized capabilities in conducting complex multi-centered trials that evaluate oncological safety of alternative treatment modalities. Their research portfolio includes studies comparing completion surgery with adjuvant chemoradiotherapy following local excision procedures, particularly for intermediate-risk early rectal cancer patients. This work represents a commitment to identifying less invasive treatment options while maintaining optimal patient outcomes and quality of life.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Amsterdam UMC Stichting1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Radboud Translational Medicine B.V.
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Oncological Safety of Rectal Preserving Therapy with Capecitabine in Intermediate-Risk Early Rectal Cancer: A Multicenter Randomized Trial | Amsterdam UMC Stichting | Phase III | Recruiting | Jan 2025 | — |
IMP list
lock Showing 1 of 9 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| (S)-4-(4-(3-CHLORO-4-(1-(5-FLUOROPYRIDIN-2-YL)-2-HYDROXYETHOXY)PYRAZOLO[1,5-A]PYRIDIN-6-YL)-5-METHYL-1H-1,2,3-TRIAZOL-1-YL)PIPERIDINE-1-CARBONITRILE | 1 | Unknown | 2026-07-14 | 2026-07-14 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.